David Shook

Companies

• Lyell Immunopharma, Inc.Chief Medical Officer Jun 11, 2025 to now¹
• Nkarta Therapeutics (United States)Chief Medical Officer Jan 10, 2023 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NTNkarta Therapeutics (United States) NKTX190,955 shares³$368.5K at $1.93Jan 15, 2025
• LILyell Immunopharma, Inc. LYEL20,423 shares⁴$167.3K at $8.19Sep 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 10, 2026Sold 500 shares at $12.70 of Lyell Immunopharma, Inc.⁴
• Jun 10, 2026Sold 1,977 shares at $12.64 of Lyell Immunopharma, Inc.⁵
• Jun 9, 2025Granted 21,900 shares of Lyell Immunopharma, Inc.⁶
• Jan 15, 2025Sold 8,638 shares at $2.20 of Nkarta Therapeutics (United States)³
• Jan 3, 2025Granted 59,000 shares of Nkarta Therapeutics (United States)⁷
• Aug 21, 2024Granted 1,352 shares at $5.11 of Nkarta Therapeutics (United States)⁸
• Jul 15, 2024Granted 23,421 shares of Nkarta Therapeutics (United States)⁹
• Jun 18, 2024Sold 456 shares at $5.60 of Nkarta Therapeutics (United States)¹⁰
• Jan 16, 2024Sold 3,552 shares at $8.74 of Nkarta Therapeutics (United States)¹¹
• Jan 4, 2024Granted 56,000 shares of Nkarta Therapeutics (United States)¹²
• Aug 21, 2023Sold 1,331 shares at $1.83 of Nkarta Therapeutics (United States)¹³
• Jun 20, 2023Sold 439 shares at $4.85 of Nkarta Therapeutics (United States)¹⁴
• Jan 17, 2023Sold 175 shares at $5.49 of Nkarta Therapeutics (United States)¹⁵
• Jan 13, 2023Granted 37,500 shares of Nkarta Therapeutics (United States)¹⁵